News Snapshot:
PETALING JAYA, 9 JULY 2022 – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”; Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group’s wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (“MGRCT”), is collaborating with Rinani Genotec Sdn Bhd (“Genotec”) to offer sports-based genetic tests. Genotec, a biomedical technology firm focusing on stem cell treatment and genetic testing, now offers a direct-to-consumer sports and fitness DNA test which enables individuals to better understand their genetic profile in sports and fitness-related areas. The test result includes categories such as energy metabolism and utilisation, muscle...
